Blog Posts.

Read on to learn about the new Pharmora Journal Club, and what we learnt from it….

Celebrating the World Cervical Awareness Week, our CMO reflects on patients she has known with cervical cancer, and her personal experience with cervical screening…

Celebrating the World Cervical Awareness Week, we would like to take this opportunity to reflect on cervical cancer, its causes, how it could be prevented, and getting an early diagnosis through screening…

**Enzyme discovered that creates universal donor blood!**
The 14th of June is World Blood Donor Day and we at Pharmora would like to take the opportunity to look at this day and discuss what impact blood donations can have…

This week is Men’s Health Week (10th – 16th June 2024)! Please read to learn more about Men’s Health, research and health tips and current medical advancements.

Read about the 9th Global Pharmacovigilance & RWE Forum, attended by Pharmora Scientists last week.

Pharmora were invited to present to the attendees of the BioNow Careers Fair. Find out how it went in this post from the presenter herself.

Find out what it is like to join Pharmora as Hannah describes her first weeks in the organization.

After attending the BioNow BioInfect conference in February, Pharmora have been inspired to create a series of blogs. This is the first summary blog to start the series, read on to learn more about the rising problem of Anti-Microbial Resistance and the scientists working to combat it.

One of the most daunting challenges in medicine is the increase in antimicrobial resistance, threatening to unravel years of scientific progress. Bacteria have evolved to resist the once-reliable therapies researched by an uncountable number of academics worldwide.

In advance of attending the BioInfect conference this week, we are pleased to present the latest blog from one of our scientists Amy Bonsall.

Pharmora has supported clients to develop many different types of anti-microbials and this blog describes an exciting potential option to help combat antibiotic resistance.

When medicines are first introduced to market, although there has been extensive research done in a clinical environment, it’s known that only the more common adverse events are likely to have presented themselves due to the small sample size.